» Articles » PMID: 23145063

Relationship Between the Inflammatory Molecular Profile of Breast Carcinomas and Distant Metastasis Development

Overview
Journal PLoS One
Date 2012 Nov 13
PMID 23145063
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory conditions may promote tumor progression and aggressiveness. In previous reports, we found a group of breast cancer tumors characterized by metalloprotease-11 (MMP-11) expression by intratumoral mononuclear inflammatory cells (MICs), which was associated with distant metastasis development. Thus, in the present study we evaluated the relationship between MMP-11 expression by MICs, distant metastasis development, and a wide panel of inflammatory factors in breast carcinoma. In an initial approach, we analyzed 65 factors associated with tumor progression and inflammation, in a tumor population classified in good or bad prognosis, based on MMP-11 expression by intratumoral MICs. The most differentially expressed factors were then analyzed in a wider tumor population classified according to MMP-11 expression by MICs and also according to metastasis development. These analyses were carried out by Real-time PCR. The results showed that of the 65 starting factors analyzed, those related with MMP-11 expression by MICs were: IL-1, -5, -6, -8, -17, -18, MMP-1, TIMP-1, ADAM-8, -10, -15, -23, ADAMTS-1, -2, -15, Annexin A2, IFNβ, Claudin-3, CCL-3, MyD88, IRAK-4 and NFκB. Of them, factors more differentially expressed between both groups of tumors were IL-1, IL-5, IL-6, IL-17, IFNβ and NFκB. Thereafter, we confirmed in the wider tumor population, that there is a higher expression of those factors in tumors infiltrated by MMP-11 positive MICs. Altogether these results indicate that tumors developing worse prognosis and identified by MMP-11 expression by intratumoral MICs, shows an up-regulation of inflammatory-related genes.

Citing Articles

Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential.

Jou E Explor Target Antitumor Ther. 2023; 4(3):474-497.

PMID: 37455828 PMC: 10345208. DOI: 10.37349/etat.2023.00146.


Vitamin D, Th17 Lymphocytes, and Breast Cancer.

Filip-Psurska B, Zachary H, Strzykalska A, Wietrzyk J Cancers (Basel). 2022; 14(15).

PMID: 35954312 PMC: 9367508. DOI: 10.3390/cancers14153649.


Gene Expression Profile of Stromal Factors in Cancer-Associated Fibroblasts from Prostate Cancer.

Eiro N, Fernandez-Gomez J, Gonzalez-Ruiz de Leon C, Fraile M, Gonzalez-Suarez J, Lobo-Rodriguez B Diagnostics (Basel). 2022; 12(7).

PMID: 35885510 PMC: 9325062. DOI: 10.3390/diagnostics12071605.


The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?.

Benot-Dominguez R, Cimini A, Barone D, Giordano A, Pentimalli F Cancers (Basel). 2022; 14(11).

PMID: 35681689 PMC: 9179653. DOI: 10.3390/cancers14112709.


Joint Tumor Bud-MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma.

Gonzalez L, Eiro N, Fraile M, Sanchez R, Andicoechea A, Fernandez-Francos S Biomedicines. 2021; 9(2).

PMID: 33669393 PMC: 7920253. DOI: 10.3390/biomedicines9020196.


References
1.
Guzman M, Rossi R, Neelakantan S, Li X, Corbett C, Hassane D . An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood. 2007; 110(13):4427-35. PMC: 2234793. DOI: 10.1182/blood-2007-05-090621. View

2.
J Marrogi A, Munshi A, Merogi A, Ohadike Y, Marrogi O, Freeman S . Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer. 1997; 74(5):492-501. DOI: 10.1002/(sici)1097-0215(19971021)74:5<492::aid-ijc3>3.0.co;2-z. View

3.
Numasaki M, Fukushi J, Ono M, Narula S, Zavodny P, Kudo T . Interleukin-17 promotes angiogenesis and tumor growth. Blood. 2002; 101(7):2620-7. DOI: 10.1182/blood-2002-05-1461. View

4.
Salven P, Hattori K, Heissig B, Rafii S . Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 2002; 16(11):1471-3. DOI: 10.1096/fj.02-0134fje. View

5.
Gemma A, Takenaka K, Hosoya Y, MATUDA K, Seike M, Kurimoto F . Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. Eur J Cancer. 2001; 37(12):1554-61. DOI: 10.1016/s0959-8049(01)00154-x. View